Literature DB >> 7562949

Development of a potent thrombin receptor ligand.

D M Feng1, D F Veber, T M Connolly, C Condra, M J Tang, R F Nutt.   

Abstract

The N-terminal thrombin receptor peptide H-Ser-Phe-Leu-Leu-Arg-Asn-Pro-Asn-Asp-Lys-Tyr-Glu-Pro-Phe-OH (1) fully activates the thrombin receptor with an EC50 of 10 microM. Structural features in the tetradecapeptide which are responsible for receptor activation have been elucidated. Agonist potency has been enhanced 1000-fold with the design of the shortened peptide H-Ala-Phe(p-F)-Arg-Cha-HArg-Tyr-NH2 (56). This analog exhibits an EC50 of 0.01 microM and is the most potent agonist for receptor activation reported to date. The monoiodinated derivative H-Ala-Phe(p-F)-Arg-Cha-HArg-Tyr(3-I)-NH2 (59) exhibits an EC50 of 0.03 microM, a level sufficient for development of a radioligand.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7562949     DOI: 10.1021/jm00020a029

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  9 in total

1.  Design, synthesis, and biological characterization of a peptide-mimetic antagonist for a tethered-ligand receptor.

Authors:  P Andrade-Gordon; B E Maryanoff; C K Derian; H C Zhang; M F Addo; A L Darrow; A J Eckardt; W J Hoekstra; D F McComsey; D Oksenberg; E E Reynolds; R J Santulli; R M Scarborough; C E Smith; K B White
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

2.  Desensitisation of protease-activated receptor-1 (PAR-1) in rat astrocytes: evidence for a novel mechanism for terminating Ca2+ signalling evoked by the tethered ligand.

Authors:  J J Ubl; M Sergeeva; G Reiser
Journal:  J Physiol       Date:  2000-06-01       Impact factor: 5.182

3.  Thrombin-induced growth cone collapse: involvement of phospholipase A(2) and eicosanoid generation.

Authors:  B A de La Houssaye; K Mikule; D Nikolic; K H Pfenninger
Journal:  J Neurosci       Date:  1999-12-15       Impact factor: 6.167

4.  The chemistry and pharmacology of privileged pyrroloquinazolines.

Authors:  Bo Chao; Bingbing X Li; Xiangshu Xiao
Journal:  Medchemcomm       Date:  2015-04-01       Impact factor: 3.597

5.  The protease thrombin is an endogenous mediator of hippocampal neuroprotection against ischemia at low concentrations but causes degeneration at high concentrations.

Authors:  F Striggow; M Riek; J Breder; P Henrich-Noack; K G Reymann; G Reiser
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-29       Impact factor: 11.205

6.  Absence of platelet CD40L identifies patients with X-linked hyper IgM syndrome.

Authors:  D P Inwald; M J Peters; D Walshe; A Jones; E G Davies; N J Klein
Journal:  Clin Exp Immunol       Date:  2000-06       Impact factor: 4.330

7.  Imaging G protein-coupled receptors while quantifying their ligand-binding free-energy landscape.

Authors:  David Alsteens; Moritz Pfreundschuh; Cheng Zhang; Patrizia M Spoerri; Shaun R Coughlin; Brian K Kobilka; Daniel J Müller
Journal:  Nat Methods       Date:  2015-07-13       Impact factor: 28.547

Review 8.  Protease-Activated Receptors in the Intestine: Focus on Inflammation and Cancer.

Authors:  Morgane Sébert; Nuria Sola-Tapias; Emmanuel Mas; Frédérick Barreau; Audrey Ferrand
Journal:  Front Endocrinol (Lausanne)       Date:  2019-10-24       Impact factor: 5.555

Review 9.  The Evolving Concept of Neuro-Thromboinflammation for Neurodegenerative Disorders and Neurotrauma: A Rationale for PAR1-Targeting Therapies.

Authors:  Barry W Festoff; Chris Dockendorff
Journal:  Biomolecules       Date:  2021-10-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.